Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

ClinicalTrials.gov ID: NCT00043849

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00043849. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 11:51 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary aim of this study is to determine the safety and efficacy of quetiapine (Seroquel) for the treatment of psychosis and/or agitation in patients with primary dementia complicated by coexistent parkinsonism, or patients with Parkinson's disease with dementia \[PDD\] who have episodes of agitation or psychosis. The secondary aim is to determine the safety and tolerability, particularly the influence on parkinsonism, of quetiapine when used to treat psychosis and/or agitation in patients with dementia complicated by coexistent parkinsonism.

Study identification

NCT ID
NCT00043849
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Enrollment
60 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2002 (Type not available)
Primary completion
Jun 2005 (Actual)
Completion
Jun 2005 (Actual)
Last update posted
Dec 11, 2009

2002 – 2005

United States locations

U.S. sites
21
U.S. states
11
U.S. cities
21
Facility City State ZIP Site status
University of Alabama at Birmingham, Alzheimer's Disease Research Center Birmingham Alabama 35233-0017 —
University of California, San Diego, Alzheimer's Disease Center La Jolla California 92037 —
VA Healthcare System Long Beach Long Beach California 90822 —
University of California at Los Angeles, Alzheimer's Disease Center Los Angeles California 90095-1769 —
Stanford/VA Aging Clinical Research Center, Department of Psychiatry & Behavioral Sciences Palo Alto California 94304 —
Emory University, Alzheimer's Disease Center Atlanta Georgia 30322 —
Medical College of Georgia Augusta Georgia 30912 —
Rush University Medical Center Chicago Illinois 60612 —
Southern Illinois University, School of Medicine Springfield Illinois 62702 —
E. N. Rogers Memorial Veterans Hospital Bedford Massachusetts 01730 —
University of Nevada Las Vegas Nevada 89102 —
Parkinson's Disease and Movement Disorders Center, Albany Medical College Albany New York 12205 —
Maimonides Medical Center Brooklyn New York 11219 —
Columbia University, Alzheimer's Disease Research Center New York New York 10032 —
University of Rochester Medical Center, Alzheimer's Disease Center Rochester New York 14620 —
Syracuse VA Medical Center Syracuse New York 13210 —
University of Pittsburgh, Alzheimer's Disease Research Center Pittsburgh Pennsylvania 15213-2593 —
University of Texas Southwestern Medical Center at Dallas, Alzheimer's Disease Center Dallas Texas 75390-9070 —
Memory Clinic at Southwestern Vermont Medical Center Bennington Vermont 05201 —
Fletcher Allan Health Care, Inc. Burlington Vermont 05401 —
University of Washington at Seattle, Alzheimer's Disease Research Center Seattle Washington 98108-1597 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00043849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 11, 2009 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.